Dataset: 11.1K articles from the COVID-19 Open Research Dataset (PMC Open Access subset)
All articles are made available under a Creative Commons or similar license. Specific licensing information for individual articles can be found in the PMC source and CORD-19 metadata
.
More datasets: Wikipedia | CORD-19

Logo Beuth University of Applied Sciences Berlin

Made by DATEXIS (Data Science and Text-based Information Systems) at Beuth University of Applied Sciences Berlin

Deep Learning Technology: Sebastian Arnold, Betty van Aken, Paul Grundmann, Felix A. Gers and Alexander Löser. Learning Contextualized Document Representations for Healthcare Answer Retrieval. The Web Conference 2020 (WWW'20)

Funded by The Federal Ministry for Economic Affairs and Energy; Grant: 01MD19013D, Smart-MD Project, Digital Technologies

Imprint / Contact

Results for Query ‹ Parainfluenzal pneumonia medication

Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children – Conclusions

Viral Pneumonia Requiring Differentiation from Acute and Progressive Diffuse Interstitial Lung Diseases – Treatment of patients with viral pneumonia

Outcomes of Early Administration of Cidofovir in Non-Immunocompromised Patients with Severe Adenovirus Pneumonia – Conclusions

Respiratory virus is a real pathogen in immunocompetent community-acquired pneumonia: comparing to influenza like illness and volunteer controls – Pre-publication history

The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis – Conclusions

Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults – Endpoints

Respiratory virus surveillance in hospitalised pneumonia patients on the Thailand-Myanmar border – Pre-publication history

Viral etiology of pneumonia among severely malnourished under-five children in an urban hospital, Bangladesh – Ethical consideration

Antibody Treatment against Angiopoietin-Like 4 Reduces Pulmonary Edema and Injury in Secondary Pneumococcal Pneumonia – Synergistic actions of antibodies with antibiotics mitigate pulmonary tissue damage and edema and prolong the survival of mice with secondary bacterial pneumonia.

The changes of prevalence and etiology of pediatric pneumonia from National Emergency Department Information System in Korea, between 2007 and 2014 – Materials and methods

Outcomes of Early Administration of Cidofovir in Non-Immunocompromised Patients with Severe Adenovirus Pneumonia – Clinical responses to antiviral therapy in each study patient

Community-acquired pneumonia in children — a changing spectrum of disease – Management — recent advances

Impact of preceding respiratory viral infections on the clinical severity of patients with pneumococcal pneumonia – Antimicrobial treatment and clinical outcome

Is Fever a Red Flag for Bacterial Pneumonia in Children With Viral – Ethical Approval and Informed Consent

Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship – Conclusions

Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator Therapy – 5. Treatment

Is Fever a Red Flag for Bacterial Pneumonia in Children With Viral – Introduction

Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia – 2) Suspected P. aeruginosa infection

Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship – Discussion

Major advances in managing community-acquired pneumonia – Summary and future directions

Major advances in managing community-acquired pneumonia – Corticosteroids

Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia – 1) P. aeruginosa infection is not suspected

Acute respiratory infections in hospitalized children in Vientiane, Lao PDR – the importance of Respiratory Syncytial Virus – Statistical analysis

Antibody Treatment against Angiopoietin-Like 4 Reduces Pulmonary Edema and Injury in Secondary Pneumococcal Pneumonia – Immunoneutralization of pneumococcal pneumolysin abrogates its pore-forming action on alveolar epithelium.

Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator Therapy – 6. Conclusions